Allergy Unit, Complesso Integrato Columbus, Rome, Italy.
Clin Exp Allergy. 2011 Jan;41(1):96-103. doi: 10.1111/j.1365-2222.2010.03648.x.
Provocation tests (PTs) with the suspected compounds are considered the 'gold standard' for establishing or excluding a diagnosis of hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs). However, only a few studies have evaluated the potential determinants of positive responses to PTs.
The aims of this study are to assess the reliability of clinical histories as indicators of NSAID hypersensitivity, as well as the risk factors for a positive PT.
Two hundred and seventy-five subjects with an unequivocal history of NSAID hypersensitivity reactions underwent PTs with the suspected drugs. To establish the potential determinants of positive PTs, we examined the following variables: gender, age at the time of reaction (<40 or ≥40 years), family and personal histories of atopy, patients who had reacted to one or more NSAIDs, time interval between drug intake and symptom onset (immediate or non-immediate reactions), time interval between the last drug reaction and the allergologic examination (≤12 or >12 months), and inclusion in a category of the Stevenson et al. classification.
Two hundred and fourteen (77.8%) subjects tolerated the suspected drugs and 61 (22.2%) reacted. Age <40 years, male gender, immediate reactions, and time interval ≤12 months were significant risk factors for a positive PT.
Our study confirms that clinical histories are not reliable tools for diagnosing NSAID hypersensitivity. Therefore, we recommend that suspected cases should undergo drug PTs. However, further studies on large samples of NSAID-sensitive patients are necessary to establish the risk factors that allow the number of candidates for PTs to be reduced.
用可疑化合物进行激发试验(PT)被认为是确定或排除非甾体抗炎药(NSAIDs)过敏的“金标准”。然而,只有少数研究评估了 PT 阳性反应的潜在决定因素。
本研究旨在评估临床病史作为 NSAIDs 过敏指示的可靠性,以及 PT 阳性的危险因素。
275 名明确有 NSAIDs 过敏反应史的患者接受了可疑药物的 PT。为了确定 PT 阳性的潜在决定因素,我们检查了以下变量:性别、反应时的年龄(<40 岁或≥40 岁)、家族和个人过敏史、对一种或多种 NSAIDs 有反应的患者、药物摄入与症状出现之间的时间间隔(立即或非立即反应)、末次药物反应与过敏检查之间的时间间隔(≤12 个月或>12 个月),以及史蒂文森等分类中的类别。
214 名(77.8%)患者耐受了可疑药物,61 名(22.2%)有反应。<40 岁、男性、立即反应和时间间隔≤12 个月是 PT 阳性的显著危险因素。
本研究证实,临床病史不是诊断 NSAIDs 过敏的可靠工具。因此,我们建议疑似病例应进行药物 PT。然而,需要对大量 NSAIDs 敏感患者进行进一步研究,以确定可减少 PT 候选人数的危险因素。